Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microbiome-Focused Intervention for HIV Susceptibility
NCT03412071Phase 2Unknown
- Sponsor
- University of Toronto
- Start
- Dec 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tinidazole, metronidazole, clindamycin, hydrogen peroxide gel in human immunodeficiency virus infection (HIV), sponsored by University of Toronto. Status: unknown.
02
Drugs
tinidazolemetronidazoleclindamycinhydrogen peroxide gel
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03412071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03412071.